drugset / Trial / NCT02504606
Safety and Pharmacokinetics of Besylsartan Tablet in Healthy Male Subject
Non-randomizedCrossoverOpen-labelTreatment
Summary
This clinical trial was evaluated to compare the safety and pharmacokinetics of Besylsartan with Amosartan, which was available commercially after single oral dose in healthy male subjects.
Timeline
- Start
- 2014-09
- Primary completion
- 2014-10
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipin besylate | Unknown | 6.944 mg | Oral |
| Subject | Amlodipin besylate | Unknown | 7.841 mg | Oral |
| Comparator | Losartan K | Unknown | 100 mg | Oral |